The supplementation of vitamin D deficiency with ergocalciferol is a simple and cost effective measure but we were unable to demonstrate its benefit on EPO requirement and hospitalization rate in hemodialysis patients. The gene discussed is EPO; the disease is vitamin D deficiency.